SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-314322
Filing Date
2020-12-10
Accepted
2020-12-10 06:06:58
Documents
1
Effectiveness Date
2020-12-10

Document Format Files

Seq Description Document Type Size
1 DEFA14A d41641ddefa14a.htm DEFA14A 32551
  Complete submission text file 0001193125-20-314322.txt   33672
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 201379356
SIC: 2834 Pharmaceutical Preparations